Erin S. Calipari

Erin S. Calipari

Auto-generated profile, based on publicly available information

Erin S. Calipari

Department of Pharmacology, Vanderbilt University

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 September 2020 in Nature
Verified
Journal Article
Closed access
PDF file
ABAna Badimon
Ana Badimon
HSHayley J. Strasburger
Hayley J. Strasburger
PAPinar Ayata
Pinar Ayata
XCXinhong Chen
Xinhong Chen
ANAditya Nair
Aditya Nair
ASAnne Schaefer
Anne Schaefer

21 August 2017 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
BLBenoit Labonté
Benoit Labonté
OEOlivia Engmann
Olivia Engmann
IPImmanuel Purushothaman
Immanuel Purushothaman
CMCaroline Menard
Caroline Menard
JWJunshi Wang
Junshi Wang
ENEric J Nestler
Eric J Nestler

10 January 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
ECErin S. Calipari
Erin S. Calipari
BJBarbara Juarez
Barbara Juarez
CMCarole Morel
Carole Morel
DWDeena M. Walker
Deena M. Walker
MCMichael Cahill
Michael Cahill
ENEric J Nestler
Eric J Nestler
Although both males and females become addicted to cocaine, females transition to addiction faster and experience greater difficulties remaining abstinent. We demonstrate an oestrous cycle-dependent mechanism controlling increased cocaine reward in females. During oestrus, ventral tegmental area (VTA) dopamine neuron activity is enhanced and drives post translational modifications at the dopamine transporter (DAT) to increase the ability of cocaine to inhibit its function, an effect mediated by estradiol. Female mice conditioned to associate cocaine with contextual cues during oestrus have enhanced mesolimbic responses to these cues in the absence of drug. Using chemogenetic approaches, we increase VTA activity to mechanistically link oestrous cycle-dependent enhancement of VTA firing to enhanced cocaine affinity at DAT and subsequent reward processing. These data have implications for sexual dimorphism in addiction vulnerability and define a mechanism by which cellular activity results in protein alterations that contribute to dysfunctional learning and reward processing.

1 February 2016 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ECErin S. Calipari
Erin S. Calipari
RBRosemary C. Bagot
Rosemary C. Bagot
IPImmanuel Purushothaman
Immanuel Purushothaman
TDThomas J. Davidson
Thomas J. Davidson
JYJordan T. Yorgason
Jordan T. Yorgason
ENEric J Nestler
Eric J Nestler
Significance: Strong associations between cocaine and the environmental contexts where cocaine is administered are thought to drive relapse. The nucleus accumbens (NAc) encodes these cue–reward associations, and here we determined how cocaine alters the ability of cells in NAc to respond to drug-associated environmental stimuli to drive drug seeking. Using fiber photometry calcium imaging we define the specific population of cells, dopamine D1 receptor-expressing neurons, that encodes information about drug associations and show that these cells can be manipulated to attenuate the strength of drug associations and prevent relapse. Together, these data define a basic circuit mechanism underlying drug–context associations and suggest that pharmacotherapeutic agents aimed at D1-type neurons may help to promote sustained abstinence in cocaine abusers.

16 January 2018 in Nature Communications
Verified
Journal Article
Open access
PDF file
ECErin S. Calipari
Erin S. Calipari
AGArthur Godino
Arthur Godino
EPEmily G. Peck
Emily G. Peck
MSMarine Salery
Marine Salery
NMNicholas L. Mervosh
Nicholas L. Mervosh
DKDrew Kiraly
Drew Kiraly
Cocaine addiction is characterized by dysfunction in reward-related brain circuits, leading to maladaptive motivation to seek and take the drug. There are currently no clinically available pharmacotherapies to treat cocaine addiction. Through a broad screen of innate immune mediators, we identify granulocyte-colony stimulating factor (G-CSF) as a potent mediator of cocaine-induced adaptations. Here we report that G-CSF potentiates cocaine-induced increases in neural activity in the nucleus accumbens (NAc) and prefrontal cortex. In addition, G-CSF injections potentiate cocaine place preference and enhance motivation to self-administer cocaine, while not affecting responses to natural rewards. Infusion of G-CSF neutralizing antibody into NAc blocks the ability of G-CSF to modulate cocaine’s behavioral effects, providing a direct link between central G-CSF action in NAc and cocaine reward. These results demonstrate that manipulating G-CSF is sufficient to alter the motivation for cocaine, but not natural rewards, providing a pharmacotherapeutic avenue to manipulate addictive behaviors without abuse potential.

15 September 2021 in Current Biology
Verified
Journal Article
Closed access
MKMunir Gunes Kutlu
Munir Gunes Kutlu
JZJennifer E. Zachry
Jennifer E. Zachry
PMPatrick R. Melugin
Patrick R. Melugin
SCStephanie A. Cajigas
Stephanie A. Cajigas
MCMaxime F. Chevee
Maxime F. Chevee
ECErin S. Calipari
Erin S. Calipari